The British Society for Rheumatology would like to acknowledge and thank our sponsors and exhibitors for their generous support.
For details of the innovation and symposia sessions at the event, click here.
 |
AbbVie Ltd AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.co.uk AbbVie will be hosting a symposium at 18.00 on Thursday 15 October. |
 |
Eli Lilly & Company Ltd Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Lilly will be hosting a 30 minute innovation session at 12:15 on 16 October |
 |
Internis Pharmaceuticals Ltd www.internisvitd3.com Founded in 2010, Internis is a UK speciality pharmaceutical company in the bone disorder arena Current work: Internis launched Accrete D3 (calcium/colecalciferol tablets) on to the UK market during 2011. In early 2012, it launched FultiumD3 800IU capsules (colecalciferol 800IU equivalent to 20 micrograms vitamin D3), the range has subsequently developed with 2 more strengths being launched to date. |
 |
Intrapharm Labs Intrapharm Laboratories are pleased to announce the relaunch of Triamcinolone Hexacetonide (formerly known as Lederspan) it has the longest duration of action and is indicated for intraarticular, intrasynovial or periarticular use in adults and adolescents (3 to 12 years) for the symptomatic treatment of subacute and chronic inflammatory joint diseases. |
 |
Janssen Pharmaceuticals Janssen will be hosting a 30 minute innovation session at 12:35 on 15 October and will be available to visit in the exhibition hall. Janssen will be hosting a 30 minute innovation session at 12:35 on 15 October |
 |
MSD MSD operates in more than 140 countries and focuses on prescription medicines, vaccines, biologic therapies, and animal health products. The company is called MSD everywhere, except in the United States and Canada, where we are known as Merck & Co., Inc., Kenilworth, NJ, USA. For more information visit www.msd-uk.com. |
 |
National Locums Ltd Your clever thinking, job finding, hard working, support giving healthcare heroes. If you’re a locum seeking the best opportunities in the NHS and independent hospitals, or you are a hospital looking for first-class, fully compliant locum doctors, nurses and AHP’s, then we’re here to help.
|
 |
Novartis Pharmaceuticals UK Novartis Pharmaceuticals is committed to developing innovative medicines to enhance health outcomes for patients and healthcare professionals. We are one of the healthcare industry’s biggest investors in research and development. By 2016 Novartis will undertake more clinical trials in the UK than any other company. Because of our discovery and development efforts, Novartis has one of the strongest and most productive pipelines in the industry. Novartis will be hosting a 30 minute innovation session at 10.50 on 15 October |
 |
Pfizer We are Pfizer, one of the world’s premier innovative biopharmaceutical companies, discovering, developing and providing over 100 different medicines, vaccines and consumer healthcare products that help save and transform the lives of millions of people in the UK and around the world every year. Pfizer will be hosting a symposium session at 08.00 on 16 October. |
 |
Sobi Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on inflammation and genetic diseases, with three late stage biological development projects within hemophilia and neonatology. Sobi will be hosting a 30 minute innovation session at 15:05 on 15 October |
 |
The MDU The MDU is a not-for-profit organisation dedicated to its members’ interests. We provide expert guidance, personal support and robust defence in addressing medico-legal issues, complaints and claims. We give high quality, specialised medico-legal advice, 24 hours a day, 7 days a week. Our team is led by doctors with real-life experience of the pressures and challenges doctor’s face in practice.
|
 |
UCB UCB, Brussels, Belgium (www.ucbpharma.co.uk) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. |
